Unitedhealth Group Inc [UNH] stock is trading at $330.11, down -0.62%. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The UNH shares have gain 1.63% over the last week, with a monthly amount glided 2.13%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Unitedhealth Group Inc [NYSE: UNH] stock has seen the most recent analyst activity on October 29, 2025, when Deutsche Bank downgraded its rating to a Hold but kept the price target unchanged to $333 for it. Previously, Goldman started tracking the stock with Buy rating on October 14, 2025, and set its price target to $406. On July 31, 2025, downgrade downgraded it’s rating to Underperform but maintained its price target of $198 on the stock. Oppenheimer reiterated its Outperform rating and decreased its price target to $325 on July 30, 2025. Robert W. Baird downgraded its rating to a Neutral but $312 remained the price target by the analyst firm on June 11, 2025. HSBC Securities downgraded its rating to Reduce for this stock on May 21, 2025, but kept the price target unchanged to $270. In a note dated May 19, 2025, TD Cowen downgraded a Hold rating on this stock but restated the target price of $308.
Unitedhealth Group Inc [UNH] stock has fluctuated between $234.60 and $606.36 over the past year. Currently, Wall Street analysts expect the stock to reach $387.8 within the next 12 months. Unitedhealth Group Inc [NYSE: UNH] shares were valued at $330.11 at the most recent close of the market. An investor can expect a potential return of 17.48% based on the average UNH price forecast.
Analyzing the UNH fundamentals
Unitedhealth Group Inc [NYSE:UNH] reported sales of 435.16B for the trailing twelve months, which represents a growth of 12.24%. Gross Profit Margin for this corporation currently stands at 0.2% with Operating Profit Margin at 0.06%, Pretax Profit Margin comes in at 0.05%, and Net Profit Margin reading is 0.04%. To continue investigating profitability, this company’s Return on Assets is posted at 0.06, Equity is 0.19 and Total Capital is 0.13. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.84.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 328.88 points at the first support level, and at 327.66 for the second support level. However, for the 1st resistance point, the stock is sitting at 332.33, and for the 2nd resistance point, it is at 334.56.
Ratios To Look Out For
For context, Unitedhealth Group Inc’s Current Ratio is 0.82. Considering the valuation of this stock, the price to sales ratio is 0.69, the price to book ratio is 3.12 and price to earnings (TTM) ratio is 17.23.
Transactions by insiders
Recent insider trading involved Baker Charles D., Director, that happened on Sep 11 ’25 when 27.0 shares were sold. Affiliate, James P Schadt Trust FBO Laure completed a deal on Sep 11 ’25 to buy 27.0 shares. Meanwhile, Chief Executive Officer, Optum Conway Patrick Hugh sold 589.0 shares on Jun 10 ’25.
